A cost-effectiveness analysis of nivolumab versus docetaxel for advanced non-squamous non-small cell lung cancer including PD-L1 testing.
Matter-Walstra K, Schwenkglenks M, Aebi S, Dedes K, Diebold J, Pietrini M, Klingbiel D, von Moos R, Gautschi O; SAKK.
J Thorac Oncol. 2016 Jun 13. pii: S1556-0864(16)30507-X. doi: 10.1016/j.jtho.2016.05.032. [Epub ahead of print]
Kommentar schreiben
Di
11
Okt
2022
Sailing Croatia 2022
Fr
18
Jun
2021
Sailing trip Italy Greece
16
Apr
Sa
24
2020
01
Sep
7 weeks sailing in Croatia
23
Mai
Thanks to Saskia and Patrick for these recordings
Kommentar schreiben